1-4 of 4
T Koster
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

Clinical Trials & Observations
Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster, Thomas Barba, Mathieu Gerfaud-Valentin, Arsène Mékinian, Henrique Coelho, Gaelle Fossard, Fiorenza Barraco, Lionel Galicier, Boris Bienvenu, Pierre Hirsch, Guillaume Vial, Anne Blandine Boutin, Joris Galland, Guillaume Le Guenno, Adrien Bigot, Kenneth J. Warrington, Tanaz A. Kermani, Peter C. Grayson, Bhavisha A. Patel, David B. Beck, Yvan Jamilloux, Pierre Fenaux, Pierre Sujobert
Journal: Blood
Blood (2022) 140 (8): 927–931.
https://doi.org/10.1182/blood.2022016642
Published: 2022
Includes: Supplemental data
Journal Articles

Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients

RP Lensen, FR Rosendaal, T Koster, CF Allaart, H de Ronde, JP Vandenbroucke, PH Reitsma, RM Bertina
Journal: Blood
Blood (1996) 88 (11): 4205–4208.
https://doi.org/10.1182/blood.V88.11.4205.4205
Published: 1996
Journal Articles

Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) [see comments]

T Koster, FR Rosendaal, E Briet, FJ van der Meer, LP Colly, PH Trienekens, SR Poort, PH Reitsma, JP Vandenbroucke
Journal: Blood
Blood (1995) 85 (10): 2756–2761.
https://doi.org/10.1182/blood.V85.10.2756.bloodjournal85102756
Published: 1995
Journal Articles

High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) [see comments]

FR Rosendaal, T Koster, JP Vandenbroucke, PH Reitsma
Journal: Blood
Blood (1995) 85 (6): 1504–1508.
https://doi.org/10.1182/blood.V85.6.1504.bloodjournal8561504
Published: 1995